Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.007
Neutral
RSI(14)
44.398
Neutral
STOCH(KDJ)(9,3,3)
60.117
Neutral
ATR(14)
0.034
High Vlolatility
CCI(14)
7.788
Neutral
Williams %R
42.559
Buy
TRIX(12,20)
-0.809
Sell
StochRSI(14)
38.458
Sell
Search
Avalon Globocare Corp
ALBTAdd to Watchlist
0.282USD
0.0000.00%
Close 07-21 16:00（ET）Quotes delayed by 15 min
2.37MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
-3.09%
6 Months
-64.12%
Year to Date
-76.50%
1 Year
-85.46%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
229.32%Turnover Ratio
0.282Prev. Close
0.000Low
0.00Turnover
LossP/E Static
-0.07P/B
0.00%Div Yield TTM
-146.18%ROA
4.74052wk High
1.84Volume Ratio
-7.90MNet Profit
4.10MShares
-4.7087EPS TTM
-0.07Beta
-1367.60%ROE
0.21052wk Low
16.00%Amplitude
33.06%Gross Margin
2.37MMarket Cap
-2.60Reward/Risk
8.15%Risk Rate
TradingKey Stock Score of Avalon Globocare Corp
Currency: USD Updated: 2026-07-21Key Insights
Avalon Globocare Corp's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 143 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Avalon Globocare Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Avalon Globocare Corp Highlights
StrengthsRisks
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Overvalued
The company’s latest PE is -0.06, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 83.03K shares, decreasing 34.57% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.22.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Avalon Globocare Corp News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.288
Sell
MA10
0.281
Buy
MA20
0.289
Sell
MA50
0.325
Sell
MA100
0.460
Sell
MA200
0.949
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Avalon Globocare Corp Info
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Ticker SymbolALBT
CompanyAvalon Globocare Corp
CEOJin (David)
Websitehttps://www.avalon-globocare.com/
Shareholders
Related Instruments
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Avalon Globocare Corp (ALBT)?
The current price of Avalon Globocare Corp (ALBT) is 0.28.
What is the symbol of Avalon Globocare Corp?
The ticker symbol of Avalon Globocare Corp is ALBT.
What is the 52-week high of Avalon Globocare Corp?
The 52-week high of Avalon Globocare Corp is 4.74.
What is the 52-week low of Avalon Globocare Corp?
The 52-week low of Avalon Globocare Corp is 0.21.
What is the market capitalization of Avalon Globocare Corp?
The market capitalization of Avalon Globocare Corp is 2.37M.
What is the Earnings Per Share (EPS TTM) of Avalon Globocare Corp (ALBT)?
The Earnings Per Share (EPS TTM) of Avalon Globocare Corp (ALBT) is -5.64.